Cerecor Inc.
NASDAQ: CERC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Cola
- Employees
- 30
- Headquarters
- Rockville, United States
- IPO year
- 2015
- Market cap
- $38.6M
- Website
- http://www.cerecor.com
Loading CERC…
Loading profile data…Frequently asked questions about CERC
What does Cerecor Inc. (CERC) do?
Cerecor Inc. operates as a biopharmaceutical firm dedicated to the discovery and marketing of therapeutic solutions, primarily addressing rare pediatric and orphan diseases. The company maintains an active pipeline, including: Inherited Metabolic Disorders: Advancing CERC-801 and CERC-802, both of which have successfully completed Phase I clinic...
Where does CERC trade?
Cerecor Inc. (CERC) trades on the NASDAQ Capital Market.
What sector is CERC in?
Cerecor Inc. (CERC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cerecor Inc.?
Michael Cola is the chief executive officer of Cerecor Inc. (CERC).
Where is Cerecor Inc. headquartered?
Cerecor Inc. is headquartered in United States.
Does CERC pay a dividend?
Cerecor Inc. (CERC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CERC go public?
Cerecor Inc. (CERC) completed its initial public offering in 2015.